CoChat

Pharmacokinetics and Clinical Effects of Alprazolam Following Single and Multiple Oral Doses in Patients With Panic Disorder

Ciraulo, Domenic A., Barnhill, Jamie G., Boxenbaum, Harold G., Greenblatt, David J., Smith, Randall B. · 1986 · The Journal of Clinical Pharmacology
Cited by 52

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The anxiolytic triazolobenzodiazepine alprazolam was administered to six male patients, aged 26 to 46 years, with panic disorder or agoraphobia (with panic attacks) to assess clinical effects and steady‐state pharmacokinetics following multiple dosing at three levels: 3.0 mg/d, 6.0 mg/d, and 9.0 mg/d. Multiple‐dose kinetics of alprazolam were compared with alprazolam disposition after a 1.0‐mg oral dose in the same patients. Kinetic variables after the single dose were very similar to those reported previously for healthy young male volunteers. Mean values were peak plasma concentration, 19 ng/mL; time of peak, 1.33 hours after dosage; elimination half‐life, 10.0 hours; total oral clearance, 1.11 mL/min/kg. During multiple dosage, mean steady‐state plasma concentrations (C ss) was proportional to dosing rate, and steady‐state clearance was independent of dosage. Clinical improvement was rapid, with the greatest decrement in symptoms at the 3‐mg/d dosage, at a mean C ss of 30 ng/mL. Further improvement was not seen at 6 mg/d (C ss 62 ng/mL), or at 9 mg/d (C ss, 103 ng/mL). Side effects, however, were directly related to dosage and plasma level, and increased progressively in number at the 3‐, 6‐, and 9‐mg/d dosage levels. Thus, the disposition of alprazolam in young male patients with panic disorder is essentially identical to that in healthy male volunteers of similar age. Alprazolam clearance is independent of dose and plasma concentration up to daily doses of at least 9 mg/d, with steady‐state plasma level proportional to dosing rate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1552-4604.1986.tb03526.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 52

Metadata

Authors
Ciraulo, D. A., Barnhill, J. G., Boxenbaum, H. G., Greenblatt, D. J., & Smith, R. B.
Venue
The Journal of Clinical Pharmacology
Publisher
Wiley
Published
1986-04
Volume
26
Issue
4
Pages
292-298
ISSN
  • 0021-9754 (ISSN-L)
  • 0091-2700
  • 1552-4604
OpenAlex
W2094468003
Cited by
52
References
2
FWCI
3.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetics and Clinical Effects of Alprazolam Following Single and Multiple Oral Doses in Patients With Panic Disorder. https://app.cochat.ai/papers/10.1002/j.1552-4604.1986.tb03526.x
The paper
Ciraulo, D. A., Barnhill, J. G., Boxenbaum, H. G., Greenblatt, D. J., & Smith, R. B. (1986). Pharmacokinetics and Clinical Effects of Alprazolam Following Single and Multiple Oral Doses in Patients With Panic Disorder. The Journal of Clinical Pharmacology. https://doi.org/10.1002/j.1552-4604.1986.tb03526.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.